Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Claya vs Mint Med

Claya
Graded #268

Lower grade

vs+21.900000000000006
Mint Med
Graded #22

Higher grade

The verdict

Mint Med takes it — 84.7/100 to 62.8/100.

Mint Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Low both-molecule pricing ($117/$159) and verified — but only 36 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMint Med +48
42
90
Dose & formulationMint Med +5
75
80
Clinical oversightMint Med +3
82
85
Labs & monitoringMint Med +30
53
83
FulfillmentMint Med +15
67
82
Contract termsMint Med +25
61
86
Claya · left barMint Med · right bar

The numbers

MetricClayaMint Med
WeighScore62.8/10084.7/100
GradeCB
Scorecard rank#268#22
Semaglutide$299/mo (compounded)$117/mo
Tirzepatide$299/mo (compounded)$159/mo
CoverageCoverage not published36 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Claya

Graded #268 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage
Mint Med

Graded #22 · B

Strengths

  • $117 sema / $159 tirz
  • LegitScript-verified
  • Both molecules

Where it loses points

  • Only 36 states
  • Injection-only
  • Monitoring detail sparse

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard